StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Celgene (CELG) PT Lowered to $125 at Jefferies; Reiterates Buy
October 27, 2017 8:40 AM
Jefferies lowered its price target on Celgene (NASDAQ: CELG) to $125.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Next Articles
Mizuho is Positive on Celgene (CELG)
October 27, 2017 10:31 AM
Cantor Fitzgerald Downgrades Celgene (CELG) to Neutral
October 27, 2017 7:36 AM
Celgene Corporation to Webcast at Upcoming Investor Conferences
October 27, 2017 7:30 AM
Stocks with Implied Volatility Movement
October 27, 2017 6:42 AM
UPDATE: Morgan Stanley Upgrades Celgene (CELG) to Equalweight
October 27, 2017 5:57 AM
JMP Securities Downgrades Celgene (CELG) to Market Perform Citing Valuation
October 27, 2017 3:16 AM
Raymond James Double Downgrades Celgene (CELG) to Market Perform
October 26, 2017 3:57 PM
Wells Fargo Downgrades Celgene (CELG) to Market Perform, Cuts PT 'on Serial Disappointment'
October 26, 2017 10:52 AM
Celgene (CELG) Maintained Outperform at Oppenheimer, Defends Name
October 26, 2017 10:40 AM
Stocks with increasing unusual option volume: TWTR CELG ETSY BX
October 26, 2017 9:43 AM
Pre-Open Movers 10/26: (MNOV) (BWLD) (TWTR) Higher; (IDRA) (CELG) (NTRI) Lower (more...)
October 26, 2017 9:27 AM
Celgene (CELG) Tops Q3 EPS by 4c, Sales Miss; Raises Low End of FY EPS Guidance, Offers 2020 Targets
October 26, 2017 7:34 AM
Celgene Reports Third Quarter 2017 Operating and Financial Results
October 26, 2017 7:30 AM
Dow, S&P gain but Nasdaq dips as healthcare lags
October 25, 2017 7:41 AM
